Porcine Pili Shield (Canada)

Company: Elanco

Escherichia Coli Bacterin

For Use in Animals Only

Porcine Pili Shield Indications

For use in healthy pregnant swine as an aid in the control of disease in piglets caused by K88, K99, 987P, and F41 piliated Escherichia coli.

ADJUVANT: Aluminum hydroxide.

Directions For Use

Shake well before using. Administer 2 mL intramuscularly 5 and 2 weeks prior to farrowing. Revaccinate prior to each subsequent farrowing.

Precautions

Store out of direct sunlight at 2°-8°C (35°-46°F). DO NOT FREEZE. Do not mix with other products, except as specified on the label. Use entire contents when first opened. In case of human exposure, contact a physician. Do not vaccinate within 21 days prior to slaughter. It is essential that newborn pigs receive colostrum from the vaccinated dam. Anaphylactic reactions may occur. Symptomatic treatment: Epinephrine.

Manufactured by Elanco US Inc., Fort Dodge, IA, USA.

USDA Vet. Biologics Est. Lic. No. 196.

For Elanco Canada Limited, Guelph, Ontario, Canada N1G 4T2; 1-800-265-5475.

Porcine Pili Shield, Elanco and the diagonal bar logo are trademarks of Elanco or its affiliates.

CPN: 1231081.6